BridgeBio Pharma Inc (BBIO)
25.07
-0.12
(-0.48%)
USD |
NASDAQ |
Nov 05, 11:27
BridgeBio Pharma Free Cash Flow: -419.68M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -419.68M |
| March 31, 2024 | -605.72M |
| December 31, 2023 | -529.03M |
| September 30, 2023 | -497.82M |
| June 30, 2023 | -488.08M |
| March 31, 2023 | -408.66M |
| December 31, 2022 | -425.82M |
| September 30, 2022 | -468.20M |
| June 30, 2022 | -495.30M |
| March 31, 2022 | -554.95M |
| December 31, 2021 | -546.18M |
| September 30, 2021 | -508.16M |
| Date | Value |
|---|---|
| June 30, 2021 | -477.37M |
| March 31, 2021 | -471.56M |
| December 31, 2020 | -407.23M |
| September 30, 2020 | -384.28M |
| June 30, 2020 | -302.42M |
| March 31, 2020 | -283.06M |
| December 31, 2019 | -256.22M |
| September 30, 2019 | -227.93M |
| June 30, 2019 | -216.48M |
| March 31, 2019 | -183.26M |
| December 31, 2018 | -154.82M |
Free Cash Flow Range, Past 5 Years
-605.72M
Minimum
Mar 2024
-256.22M
Maximum
Dec 2019
-448.93M
Average
-471.56M
Median
Mar 2021
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals Inc | 16.06M |
| Pfizer Inc | 4.81B |
| Vertex Pharmaceuticals Inc | -1.426B |
| PTC Therapeutics Inc | -230.14M |
| Bristol-Myers Squibb Co | 13.80B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 74.70M |
| Cash from Investing (Quarterly) | 3.039M |
| Cash from Financing (Quarterly) | -5.729M |
| Free Cash Flow Per Share (Quarterly) | 0.3852 |
| Free Cash Flow to Equity (Quarterly) | 70.59M |
| Free Cash Flow Yield | -9.51% |